The review found no eligible studies for this question.
Ahmed implant probably leads to higher mean number of antiglaucoma medications at 1‐year compared with baerveldt implant (moderate certainty).
Ahmed implant probably leads to higher proportion needing additional glaucoma surgery at 1‐year compared with baerveldt implant (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Ahmed implant showed no clear difference in mean IOP at 1‐year compared with molteno implant (low certainty).
It is very uncertain whether ahmed implant changes mean logMAR visual acuity at 1‐year compared with molteno implant (very low certainty).
It is very uncertain whether ahmed implant changes mean change in visual field score from baseline at 1‐year compared with molteno implant (very low certainty).
Ahmed implant showed no clear difference in mean number of antiglaucoma medications at 1‐year compared with molteno implant (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Ahmed implant showed no clear difference in mean IOP at 1‐year compared with baerveldt implant (moderate certainty).
Ahmed implant showed no clear difference in mean logMAR visual acuity at 1‐year compared with baerveldt implant (low certainty).